Skip to main content

Advertisement

Log in

Reply to the Letter “A different role of FDG PET/CT for axillary lymph node staging in breast cancer”

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Aukema TS, Straver ME, Valdés Olmos RA, Vogel WV. A different role of FDG PET/CT for axillary lymph node staging in breast cancer. Eur J Nucl Med Mol Imaging 2009. doi:10.1007/s00259-009-1211-0

  2. Heusner TA, Kuemmel S, Hahn S, Koeninger A, Otterbach F, Hamami ME, et al. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients. Eur J Nucl Med Mol Imaging 2009. doi:10.1007/s00259-009-1145-6

  3. Fraile M, Rull M, Julian FJ, Fuste F, Barnadas A, Llatjos M, et al. Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Ann Oncol 2000;11:701–5.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Till A. Heusner.

Additional information

This reply refers to the letter to the editor at http://dx.doi.org/10.1007/s00259-009-1211-0

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heusner, T.A., Kuemmel, S., Antoch, G. et al. Reply to the Letter “A different role of FDG PET/CT for axillary lymph node staging in breast cancer”. Eur J Nucl Med Mol Imaging 36, 1898–1899 (2009). https://doi.org/10.1007/s00259-009-1209-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-009-1209-7

Keywords

Navigation